These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 22219194)

  • 41. Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway.
    Shao B; Pennathur S; Pagani I; Oda MN; Witztum JL; Oram JF; Heinecke JW
    J Biol Chem; 2010 Jun; 285(24):18473-84. PubMed ID: 20378541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I.
    Shao B; Cavigiolio G; Brot N; Oda MN; Heinecke JW
    Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12224-9. PubMed ID: 18719109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Systematic Investigation of Structure/Function Requirements for the Apolipoprotein A-I/Lecithin Cholesterol Acyltransferase Interaction Loop of High-density Lipoprotein.
    Gu X; Wu Z; Huang Y; Wagner MA; Baleanu-Gogonea C; Mehl RA; Buffa JA; DiDonato AJ; Hazen LB; Fox PL; Gogonea V; Parks JS; DiDonato JA; Hazen SL
    J Biol Chem; 2016 Mar; 291(12):6386-95. PubMed ID: 26797122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.
    Shao B; Fu X; McDonald TO; Green PS; Uchida K; O'Brien KD; Oram JF; Heinecke JW
    J Biol Chem; 2005 Oct; 280(43):36386-96. PubMed ID: 16126721
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Function of different proportions of apolipoprotein A-I cysteine mutants and apolipoprotein A-V on recombinant high-density lipoproteins
    Yan Y; Lu S; Jia S; Dong Q; Wang L; Wang Y
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31023964
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Desmocollin 1 is abundantly expressed in atherosclerosis and impairs high-density lipoprotein biogenesis.
    Choi HY; Ruel I; Malina A; Garrod DR; Oda MN; Pelletier J; Schwertani A; Genest J
    Eur Heart J; 2018 Apr; 39(14):1194-1202. PubMed ID: 29106519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein.
    Pankhurst G; Wang XL; Wilcken DE; Baernthaler G; Panzenböck U; Raftery M; Stocker R
    J Lipid Res; 2003 Feb; 44(2):349-55. PubMed ID: 12576517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tyrosine modification is not required for myeloperoxidase-induced loss of apolipoprotein A-I functional activities.
    Peng DQ; Wu Z; Brubaker G; Zheng L; Settle M; Gross E; Kinter M; Hazen SL; Smith JD
    J Biol Chem; 2005 Oct; 280(40):33775-84. PubMed ID: 16091367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exchange of apolipoprotein A-I between lipid-associated and lipid-free states: a potential target for oxidative generation of dysfunctional high density lipoproteins.
    Cavigiolio G; Geier EG; Shao B; Heinecke JW; Oda MN
    J Biol Chem; 2010 Jun; 285(24):18847-57. PubMed ID: 20385548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage.
    White CR; Datta G; Wilson L; Palgunachari MN; Anantharamaiah GM
    Chem Phys Lipids; 2019 Mar; 219():28-35. PubMed ID: 30707910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pro- or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins?
    Vuilleumier N; Dayer JM; von Eckardstein A; Roux-Lombard P
    Swiss Med Wkly; 2013; 143():w13781. PubMed ID: 23740387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A reconstituted HDL containing V156K or R173C apoA-I exhibited anti-inflammatory activity in apo-E deficient mice and showed resistance to myeloperoxidase-mediated oxidation.
    Cho KH; Kim JR
    Exp Mol Med; 2009 Jun; 41(6):417-28. PubMed ID: 19322022
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apolipoprotein A-I but not high-density lipoproteins are internalised by RAW macrophages: roles of ATP-binding cassette transporter A1 and scavenger receptor BI.
    Lorenzi I; von Eckardstein A; Cavelier C; Radosavljevic S; Rohrer L
    J Mol Med (Berl); 2008 Feb; 86(2):171-83. PubMed ID: 17906976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ATP-binding cassette A1-mediated lipidation of apolipoprotein A-I occurs at the plasma membrane and not in the endocytic compartments.
    Denis M; Landry YD; Zha X
    J Biol Chem; 2008 Jun; 283(23):16178-86. PubMed ID: 18385134
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of Myeloperoxidase-Induced Oxidation on Antiatherogenic Functions of High-Density Lipoprotein.
    Kameda T; Ohkawa R; Yano K; Usami Y; Miyazaki A; Matsuda K; Kawasaki K; Sugano M; Kubota T; Tozuka M
    J Lipids; 2015; 2015():592594. PubMed ID: 26257958
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of myeloperoxidase in HDL oxidation and atherogenesis.
    Heinecke JW
    Curr Atheroscler Rep; 2007 Oct; 9(4):249-51. PubMed ID: 18173946
    [No Abstract]   [Full Text] [Related]  

  • 58. Thiol oxidation and di-tyrosine formation in human plasma proteins induced by inflammatory concentrations of hypochlorous acid.
    Colombo G; Clerici M; Altomare A; Rusconi F; Giustarini D; Portinaro N; Garavaglia ML; Rossi R; Dalle-Donne I; Milzani A
    J Proteomics; 2017 Jan; 152():22-32. PubMed ID: 27777179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An abundant dysfunctional apolipoprotein A1 in human atheroma.
    Huang Y; DiDonato JA; Levison BS; Schmitt D; Li L; Wu Y; Buffa J; Kim T; Gerstenecker GS; Gu X; Kadiyala CS; Wang Z; Culley MK; Hazen JE; Didonato AJ; Fu X; Berisha SZ; Peng D; Nguyen TT; Liang S; Chuang CC; Cho L; Plow EF; Fox PL; Gogonea V; Tang WH; Parks JS; Fisher EA; Smith JD; Hazen SL
    Nat Med; 2014 Feb; 20(2):193-203. PubMed ID: 24464187
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxidized plasma high-density lipoprotein is decreased in Alzheimer's disease.
    Bergt C; Nakano T; Ditterich J; DeCarli C; Eiserich JP
    Free Radic Biol Med; 2006 Nov; 41(10):1542-7. PubMed ID: 17045922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.